Computational survey of peptides derived from disulphide-bonded protein loops that may serve as mediators of protein-protein interactions

BackgroundBioactive cyclic peptides derived from natural sources are well studied, particularly those derived from non-ribosomal synthetases in fungi or bacteria. Ribosomally synthesised bioactive disulphide-bonded loops represent a large, naturally enriched library of potential bioactive compounds, worthy of systematic investigation.ResultsWe examined the distribution of short cyclic loops on the surface of a large number of proteins, especially membrane or extracellular proteins. Available three-dimensional structures highlighted a number of disulphide-bonded loops responsible for the majority of the likely binding interactions in a variety of protein complexes, due to their location at protein-protein interfaces. We find that disulphide-bonded loops at protein-protein interfaces may, but do not necessarily, show biological activity independent of their parent protein. Examining the conservation of short disulphide bonded loops in proteins, we find a small but significant increase in conservation inside these loops compared to surrounding residues. We identify a subset of these loops that exhibit a high relative conservation, particularly among peptide hormones.ConclusionsWe conclude that short disulphide-bonded loops are found in a wide variety of biological interactions. They may retain biological activity outside their parent proteins. Such structurally independent peptides may be useful as biologically active templates for the development of novel modulators of protein-protein interactions.

[1]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[2]  Chi Zhang,et al.  Pre-expression of a sulfhydryl oxidase significantly increases the yields of eukaryotic disulfide bond containing proteins expressed in the cytoplasm of E.coli , 2011, Microbial cell factories.

[3]  Jean-Michel Claverie,et al.  Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria , 2007, Proceedings of the National Academy of Sciences.

[4]  Conan K. L. Wang,et al.  CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering , 2007, Nucleic Acids Res..

[5]  S. Schreiber,et al.  The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.

[6]  S. Patel,et al.  Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors. , 2009, International journal of peptide and protein research.

[7]  C. Toniolo,et al.  Intramolecularly hydrogen-bonded peptide conformations. , 1980, CRC critical reviews in biochemistry.

[8]  Motomasa Kobayashi,et al.  Synthesis of stable analogs in blood and conformational analysis of arenastatin A, a potent cytotoxic spongean depsipeptide , 2001 .

[9]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[10]  Jason P. Mulvenna,et al.  CyBase: a database of cyclic protein sequence and structure , 2005, Nucleic Acids Res..

[11]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[12]  J. Hamman,et al.  Oral delivery of peptide drugs: barriers and developments. , 2005, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[13]  Maria Victoria Schneider,et al.  MINT: a Molecular INTeraction database. , 2002, FEBS letters.

[14]  Niall J. Haslam,et al.  Peptide-Binding Domains: Are Limp Handshakes Safest? , 2012, Science Signaling.

[15]  S. Goodman,et al.  N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. , 1999, Journal of medicinal chemistry.

[16]  Gabriele Ausiello,et al.  MINT: the Molecular INTeraction database , 2006, Nucleic Acids Res..

[17]  J. Sussman,et al.  Relationship between sequence conservation and three‐dimensional structure in a large family of esterases, lipases, and related proteins , 1993, Protein science : a publication of the Protein Society.

[18]  K. Gunasekaran,et al.  Beta-hairpins in proteins revisited: lessons for de novo design. , 1997, Protein engineering.

[19]  B X Yan,et al.  Glycine Residues Provide Flexibility for Enzyme Active Sites* , 1997, The Journal of Biological Chemistry.

[20]  D. Shaw,et al.  Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes , 2008, Nature Structural &Molecular Biology.

[21]  A. Bernkop‐Schnürch,et al.  Strategies to improve plasma half life time of peptide and protein drugs , 2006, Amino Acids.

[22]  Andrew Gould,et al.  Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery. , 2011, Current pharmaceutical design.

[23]  F. Blasi,et al.  The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy , 2003, Cancer and Metastasis Reviews.

[24]  M. Marahiel,et al.  Nonribosomal peptides: from genes to products. , 2003, Natural product reports.

[25]  Daisuke Kihara,et al.  Quality assessment of protein structure models. , 2009, Current protein & peptide science.

[26]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[27]  Hans J. Vogel,et al.  Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs , 2010, PloS one.

[28]  R. Read,et al.  How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration , 2003, Nature Structural Biology.

[29]  S Luckett,et al.  High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. , 1999, Journal of molecular biology.

[30]  D. Pei,et al.  High-throughput synthesis and screening of cyclic peptide antibiotics. , 2007, Journal of medicinal chemistry.

[31]  R. Othman,et al.  Computational identification of self‐inhibitory peptides from envelope proteins , 2012, Proteins.

[32]  Holger Gohlke,et al.  Hot Spots and Transient Pockets: Predicting the Determinants of Small-Molecule Binding to a Protein-Protein Interface , 2012, J. Chem. Inf. Model..

[33]  D. Hartl,et al.  Solvent accessibility and purifying selection within proteins of Escherichia coli and Salmonella enterica. , 2000, Molecular biology and evolution.

[34]  Jakub Pas,et al.  ELM: the status of the 2010 eukaryotic linear motif resource , 2009, Nucleic Acids Res..

[35]  G. Carpenter,et al.  ErbB receptors: new insights on mechanisms and biology. , 2006, Trends in cell biology.

[36]  Jenn-Kang Hwang,et al.  Site-specific structural constraints on protein sequence evolutionary divergence: local packing density versus solvent exposure. , 2014, Molecular biology and evolution.

[37]  D. Craik,et al.  Naturally Occurring Circular Proteins: Distribution, Biosynthesis and Evolution , 2011 .

[38]  Pierre Tufféry,et al.  A fast method for large‐scale De Novo peptide and miniprotein structure prediction , 2009, J. Comput. Chem..

[39]  Christian Gautier,et al.  VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus–host interaction networks , 2008, Nucleic Acids Res..

[40]  Christie S. Chang,et al.  The BioGRID interaction database: 2013 update , 2012, Nucleic Acids Res..

[41]  B. Charlesworth,et al.  Biological and biomedical implications of the co-evolution of pathogens and their hosts , 2002, Nature Genetics.

[42]  Nir London,et al.  Can self‐inhibitory peptides be derived from the interfaces of globular protein–protein interactions? , 2010, Proteins.

[43]  Richard J. Edwards,et al.  Bioinformatic discovery of novel bioactive peptides. , 2007, Nature chemical biology.

[44]  M. Shimaoka,et al.  Conformational regulation of integrin structure and function. , 2002, Annual review of biophysics and biomolecular structure.

[45]  Alessandro Vullo,et al.  Distill: a suite of web servers for the prediction of one-, two- and three-dimensional structural features of proteins , 2006, BMC Bioinformatics.

[46]  Ozlem Keskin,et al.  HotRegion: a database of predicted hot spot clusters , 2011, Nucleic Acids Res..

[47]  Horst Kessler,et al.  N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists , 1999 .

[48]  S. Lamberts,et al.  Drug therapy : octreotide , 1996 .

[49]  Mona Singh,et al.  Predicting functionally important residues from sequence conservation , 2007, Bioinform..

[50]  M. Selsted,et al.  θ-Defensins: Cyclic Peptides with Endless Potential* , 2012, The Journal of Biological Chemistry.

[51]  James G. Davis,et al.  Effects of Dietary Antioxidant Supplementation on the Development of Malignant Lymphoma and Other Neoplastic Lesions in Mice Exposed to Proton or Iron-Ion Radiation , 2008, Radiation research.

[52]  Bartek Wilczynski,et al.  Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..

[53]  D. Cafiso,et al.  The role of proline and glycine in determining the backbone flexibility of a channel-forming peptide. , 1999, Biophysical journal.

[54]  M. Caputi,et al.  The urokinase plasminogen activator and its receptor , 2005, Thrombosis and Haemostasis.

[55]  John A. Robinson,et al.  Protein-Loop Mimetics: A Diketopiperazine-Based Template to Stabilize Loop Conformations in Cyclic Peptides Containing the NPNA and RGD Motifs , 1996 .

[56]  Jae-Hoon Kim,et al.  Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains , 2002, Cell.

[57]  Robert S. McDowell,et al.  A Minimal Peptide Scaffold for β-Turn Display: Optimizing a Strand Position in Disulfide-Cyclized β-Hairpins , 2001 .

[58]  D. Craik,et al.  Circular proteins and mechanisms of cyclization , 2010, Biopolymers.

[59]  Jun.  Octreotide , 1989, The Lancet.